Motley Fool Premium
  1. Stocks
    2. /
  2. OXB (LSE: OXB)
    3. /

LSE:OXB (OXB)

About OXB

OXB is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. OXB, a FTSE4Good constituent, is headquartered in Oxford, UK. It has bioprocessing and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France and near Boston, MA, US.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

OXB (LSE: OXB) Latest News

Investing Articles

1 hidden growth stock I think can become a leader in this $14bn industry

| Zaven Boyrazian, CFA

Biotech has become a powerful source of growth for big pharma. Zaven Boyrazian takes a closer look at a growth…

Read more »

Investing Articles

This biotech growth stock has soared in the coronavirus pandemic. Here’s what you need to know

| Alan Oscroft

Here are two potential growth stocks, affected by Covid-19 in different ways. Their share prices have headed in opposite directions…

Read more »

Investing Articles

I believe this coronavirus stock could be a great growth opportunity

| Jabran Khan

This Fool is interested in a coronavirus stock that could be a great opportunity for your portfolio on the back…

Read more »

Investing Articles

Is the Thomas Cook share price a buy after 20% jump?

| Alan Oscroft

The Thomas Cook Group plc (LON: TCG) share price climbs in response to radical plans to turn the travel giant…

Read more »

Investing Articles

Could this small-cap biotech stock beat the UKOG share price?

| Alan Oscroft

UK Oil & Gas plc (LON: UKOG) is a growth investors' favourite, but we shouldn't overlook the potential for biotechnology…

Read more »

Investing Articles

One growth stock I’d buy alongside this Neil Woodford favourite

| Alan Oscroft

Neil Woodford has an eye for top growth shares, and here's one he might have missed.

Read more »

Investing Articles

2 great ‘hidden’ shares for growth investors

| Alan Oscroft

Here are two potential growth shares that might not be so obvious.

Read more »

Investing Articles

Should you buy this healthcare company after its 39% fall?

| Peter Stephens

This healthcare stock has endured a tough year, but is now the time to buy?

Read more »

Investing Articles

Why are these three shares climbing today?

| Alan Oscroft

These three shares are on the way up, so are they worth buying?

Read more »

Investing Articles

Should you buy Blinkx plc, Oxford BioMedica plc and Intelligent Energy Holding plc after today’s updates?

| Peter Stephens

Are these 3 stocks ripe for investment? Blinkx plc (LON: BLNX), Oxford BioMedica plc (LON: OXB) and Intelligent Energy Holding…

Read more »

Investing Articles

Why Are Lonmin Plc, Oxford BioMedica plc & Bango plc Among Today’s Biggest Gainers?

| Peter Stephens

Should you buy or sell these 3 major gainers? Lonmin Plc (LON: LMI), Oxford BioMedica plc (LON: OXB) and Bango…

Read more »

Investing Articles

Are Aminex plc, Premier Oil PLC And Oxford BioMedica plc Set For Strong Recoveries?

| Alan Oscroft

Aminex plc (LON: AEX), Premier Oil PLC (LON: PMO) and Oxford BioMedica plc (LON: OXB) are down, but they're far…

Read more »